// App-Quantinova.ai

TCT-156 : Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis

Researchers

Presenter

  • Mahesh Anantha Narayanan

Principal Investigators

  • Yogesh NV

  • Reddy

  • Dixitha Anugula

  • Nagarjuna Gujjula

  • Apurva Badheka

  • Abhishek Deshmukh

  • Manu Kaushik

  • Ganesh Raveendran

Medical Centers

  • University of Minnesota, Saint Paul, Minnesota, United States

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

  • The Everett Clinic, Everett, Washington, United States

  • University of Minnesota, Saint Paul, Minnesota, United States

  • Creighton University Medical Center, Omaha, Nebraska, United States

  • NWI VA Medical Center, Omaha, Nebraska, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved